Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

404 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunology and targeted therapy in Castleman disease.
Tsunoda S, Harada T, Kikushige Y, Kishimoto T, Yoshizaki K. Tsunoda S, et al. Among authors: yoshizaki k. Expert Rev Clin Immunol. 2024 May 27:1-12. doi: 10.1080/1744666X.2024.2357689. Online ahead of print. Expert Rev Clin Immunol. 2024. PMID: 38785062 Review.
Fragrances as a trigger of immune responses in different environments.
Macchione M, Yoshizaki K, Frias DP, Maier K, Smelan J, Prado CM, Mauad T. Macchione M, et al. Among authors: yoshizaki k. Toxicol In Vitro. 2024 Apr;96:105769. doi: 10.1016/j.tiv.2023.105769. Epub 2023 Dec 22. Toxicol In Vitro. 2024. PMID: 38142785 Review.
C-terminus of PIEZO1 governs Ca2+ influx and intracellular ERK1/2 signaling pathway in mechanotransduction.
Sugimoto A, Iwata K, Kurogoushi R, Tanaka M, Nakashima Y, Yamakawa Y, Oishi A, Yoshizaki K, Fukumoto S, Yamamoto A, Ishimaru N, Iwamoto T. Sugimoto A, et al. Among authors: yoshizaki k. Biochem Biophys Res Commun. 2023 Nov 19;682:39-45. doi: 10.1016/j.bbrc.2023.09.080. Epub 2023 Sep 27. Biochem Biophys Res Commun. 2023. PMID: 37801988 Free article.
Safety, efficacy and pharmacokinetics of palivizumab in off-label neonates, infants, and young children at risk for serious respiratory syncytial virus infection: a multicenter phase II clinical trial.
Mori M, Yoshizaki K, Watabe S, Ishige M, Hinoki A, Kondo T, Taguchi T, Hasegawa H, Hatata T, Tanuma N, Kirino K, Hirakawa A, Naruto T, Imai M, Koike R, Hosoi K, Kusuda S. Mori M, et al. Among authors: yoshizaki k. Lancet Reg Health West Pac. 2023 Jul 26;39:100847. doi: 10.1016/j.lanwpc.2023.100847. eCollection 2023 Oct. Lancet Reg Health West Pac. 2023. PMID: 37554997 Free PMC article.
404 results